Session 1: What's New in the Management of Type 2 Diabetes- A Personal and Professional Perspective.

Date: 4/21/2010 Check-In and Breakfast:
 7:00 am - 7:30 am
Educational Session: 7:30 am - 12:30 pm

C. Wayne Weart,Pharm.D., FASHP,FAPhA, BCPS
Professor of Family Medicine, MUSC College of Medicine
Professor of Clinical Pharmacy and Outcome Sciences,
South Carolina College of Pharmacy, MUSC Campus.

Dr. Weart is on the speakers bureau for Novartis, in the area of hypertension and Pfizer in the areas of cardiovascular disease and pain. He is a consultant for Merck in the area of outcomes research.

At the conclusion of this session, you should be able to:
  • Describe the relationship between obesity and the risk of Type 2 diabetes and the benefits of lifestyle modification (IE diet and exercise) in reducing the risk and helping to manage patients with Type 2 diabetes
  • Describe the current 2009 ADA clinical practice guidelines for the diagnosis and management of diabetes mellitus.
  • Discuss the appropriate use of insulin, exanitide and oral agents in the management of patients with Type 2 diabetes mellitus.
  • Describe the benefits of treating both blood pressure and lipids in patients with Type 2 diabetes
  • Discuss the potential benefits and risks of aggressive treatment of glucose in patients with Type 2 diabetes






[an error occurred while processing this directive]